Burrows Francisinsider trades

In SEC Form 4 filings, Burrows Francis is listed as Chief Scientific Officer of Kura Oncology, Inc. (KURA). In the last 90 days, Burrows Francis sold $224.5K of Kura Oncology, Inc. (KURA) on the open market and bought none.

Companies and roles

Company	Role	Transactions	Last filed
KURAKura Oncology, Inc.	Chief Scientific Officer	3	Sep 25

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-25

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
KURAKura Oncology, Inc.	Sep 24	Sep 25	M	30,000	$6.15	$184,500	63,053	No	Form 4
KURAKura Oncology, Inc.	Sep 24	Sep 25	S	20,726	$10.83	Sale −$224,514	42,327	No	Form 4
KURAKura Oncology, Inc.	Sep 24	Sep 25	M · derivative	30,000	$6.15	$184,500	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.